doc. RNDr. Alena Hyršlová Vaculová, Ph.D.
Lektorka II, Section of Animal Physiology and Immunology
Total number of publications: 59
2024
-
Inhibition of Chk1 stimulates cytotoxic action of platinum-based drugs and TRAIL combination in human prostate cancer cells
Biological Chemistry, year: 2024, volume: 405, edition: 6, DOI
2022
-
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma
Pharmacological Reports, year: 2022, volume: 74, edition: 1, DOI
2021
-
CHK1 INHIBITOR SCH900776 ENHANCES ANTICANCER ACTION OF CISPLATIN AND TRAIL VIA STIMULATION OF BAK-DEPENDENT MITOCHONDRIAL PATHWAY
Year: 2021, type: Conference abstract
2018
-
INHIBITION OF P300/CBP REDUCES CYP1A1 INDUCTION IN CANCER CELL MODELS DERIVED FROM THE LIVER OR COLON EPITHELIUM
Year: 2018, type: Conference abstract
2017
-
Dietary fatty acids specifically modulate phospholipid patternin colon cells with distinct differentiation capacities
European Journal of Nutrition, year: 2017, volume: 56, edition: 4, DOI
-
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
Neoplasia, year: 2017, volume: 19, edition: 10, DOI
-
INHIBITION OF CHK1 STIMULATES THE COOPERATIVE CYTOTOXIC ACTION OF PLATINUM-BASED DRUGS AND TRAIL IN HUMAN PROSTATE CANCER CELLS
Year: 2017, type: Conference abstract
-
PLATINUM-BASED DRUG-MEDIATED INCREASE OF TRAIL-INDUCED PROSTATE CANCER CELL APOPTOSIS DEPENDS ON MITOCHONDRIA BUT NOT CASPASE-10
Year: 2017, type: Conference abstract
-
The role of Chk1 in regulation of apoptosis induced by platinum-based drugs in human prostate cancer cells
Year: 2017, type: Conference abstract
2016
-
Cisplatin or LA-12-mediated stimulation of TRAIL-induced apoptosis in human prostate cancer cells involves Bax/Bak-dependent mitochondria activation
Year: 2016, type: Conference abstract